C Max Schmidt, MD, PhD
Professor of Surgery
Vice Chairman and Professor of Surgery, Biochemistry and Molecular Biology at Indiana University School of Medicine and Chief of Surgery IU Health University Hospital. He is the immediate past President of the Association for Academic Surgery Foundation (AASF).
He has served on several national surgical organizations as an officer, counselor or committee member including the AAS, SUS, SSAT, CSA, and MSA. He initiated an international outreach program to teach the fundamentals of surgical research in France and has facilitated the development of a program in Australia. Dr. Schmidt has a clinical practice focused on patients with pancreatic disease. He is an internationally recognized expert on precancerous cystic lesions of the pancreas.
He is Surgical Director of the Indiana University Health Pancreas Cyst and Cancer Early Detection Center www.pancyst.com He also leads the Robotic Pancreaticobiliary Surgery Program at Indiana University Health and has been performing robotic pancreatic surgery for nearly a decade.
Dr. Schmidt performs clinical trials and translational research directed at discovering novel biomarkers and targeted treatments of patients with pancreatic neoplasia. His research is or has been continuously funded for 14 years. Funding sources have included NIH, VA, ACS, AACR, PanCAN, Lustgarten Foundation and Bigelow-Brand Charity.
He is Founder “B9 Inc" which specializes in the development of “benign” biomarkers of disease. In the community, he has a significant following as evidenced by the Bigelow-Brand Charity Board which holds major fundraisers for his early detection Program annually. Dr. Schmidt was recently featured on the cover of Indianapolis Magazine as a 2012 Top Doc, was a 2013 Finalist for the Indianapolis Business Journal’s Health Care Heroes Award.
Specialties: Surgical Oncology, General Surgery
Conditions & Treatments: Pancreatic, Biliary, Hepatic, Pancreatic Cancer/Cysts, Surgical Oncology- Pancreas, Bile Duct, Liver, Stomach, Intestine, Adrenal, & Sarcomas, Hepatopancreatobiliary Surgery, Minimally Invasive Surgery, Robotic Surgery
School of Medicine: University of Chicago Pritzker School of Medicine
Internship: Johns Hopkins
Residency: Johns Hopkins
Fellowship: Johns Hopkins
EH 500 SGEN
Titles & Appointments
- Professor of Biochemistry & Molecular Biology
Clinical Research Interests:
Director of the Indiana University Pancreas Cyst (and Hereditary Pancreatic Cancer Screening) Clinic (IUPCC) which coordinates the care and follow-up of close to 1,000 patients with precancerous lesions of the pancreas.
Internationally recognized expert on precancerous cystic lesions of the pancreas (intraductal papillary mucinous neoplasms and mucinous cystic neoplasms).
Director of the IU Robotic Pancreaticobiliary Surgery Program: performs minimally invasive, laparoscopic and robotic pancreaticoduodenectomy (whipple), distal pancreatectomy and other complex pancreaticobiliary cases.
Basic Research Interests:
Dr. Schmidt performs clinical trials and translational research directed at discovering novel biomarkers and targeted treatments of patients with pancreatic and liver neoplasia. His research is also focused on pancreatic cancer early detection. He directs the Pancreatic Cancer and Cyst Early Detection Center (PCC-EDC). The mission of the PCC-EDC is to prevent pancreatic cancer through rigorous identification, tracking and treatment of patients "at risk" for pancreatic cancer through a multidisciplinary screening clinic, registry, community outreach, education, and research discovery. There are at present four components to the center:
IU Pancreas Cyst and Hereditary Pancreatic Cancer Screening Clinic (IUPCC)
IU Regenstrief Registry of Pancreas Cysts (IURPC)
IU Pancreas Tissue Fluid Bank (IUPTB)
IU Pancreas Cyst Biomarker Discovery Lab (IUPCL)
Dr. Schmidt's research has been funded by the National Institutes of Health (NIH), the Veteran's Affairs (VA), the American Cancer Society (ACS), the American Association for Cancer Research (AACR) and the Pancreatic Cancer Action Network (PanCAN) and the Lustgarten Foundation.